A polyethylenimine (PEI)-modified single-walled CNT conjugated with candesartan was developed to deliver VEGF-targeted siRNA (siVEGF) for the synergistic treatment of tumor angiogenesis [105]. The gene discussed is VEGFA; the disease is neoplasm.